Sonnet BioTherapeutics Holdings, Inc. (SONN): Price and Financial Metrics
SONN Price/Volume Stats
| Current price | $2.92 | 52-week high | $18.72 |
| Prev. close | $3.04 | 52-week low | $2.50 |
| Day low | $2.86 | Volume | 110,800 |
| Day high | $3.20 | Avg. volume | 135,062 |
| 50-day MA | $5.20 | Dividend yield | N/A |
| 200-day MA | $9.85 | Market Cap | 1.99M |
SONN Stock Price Chart Interactive Chart >
Sonnet BioTherapeutics Holdings, Inc. (SONN) Company Bio
Sonnet BioTherapeutics Holdings, Inc. operates as a clinical stage biotechnology company. The Company develops fully human albumin binding technology that helps the development of innovative targeted biologic drugs with enhanced single-or bi-specific mechanisms. Sonnet BioTherapeutics Holdings serves customers in the United States.
SONN Price Returns
| 1-mo | -52.13% |
| 3-mo | -51.34% |
| 6-mo | -77.88% |
| 1-year | -73.55% |
| 3-year | -99.80% |
| 5-year | -99.99% |
| YTD | -79.02% |
| 2023 | -93.12% |
| 2022 | -80.12% |
| 2021 | -81.48% |
| 2020 | -85.46% |
| 2019 | -54.26% |
Loading social stream, please wait...